CollPlant Biotechnologies to report Q3 2025 financial results on Nov. 26.

martes, 18 de noviembre de 2025, 7:05 am ET1 min de lectura
CLGN--

• CollPlant Biotechnologies to report Q3 2025 financial results on Nov 26, 2025. • Company develops non-animal-derived rhCollagen for tissue regeneration and aesthetics. • Focuses on 3D bioprinting of tissues and organs, tissue repair and medical aesthetics. • Entering into development and global commercialization agreements for new products.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios